Snowden Capital Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,660
| Closed | -$479K | – | 1217 |
|
|
2024
Q2 | $479K | Buy |
19,660
+533
| +3% | +$13K | 0.01% | 775 |
|
|
2024
Q1 | $646K | Buy |
19,127
+7,502
| +65% | +$253K | 0.02% | 648 |
|
|
2023
Q4 | $367K | Buy |
11,625
+2,248
| +24% | +$70.9K | 0.01% | 837 |
|
|
2023
Q3 | $240K | Hold |
9,377
| – | – | 0.01% | 940 |
|
|
2023
Q2 | $269K | Hold |
9,377
| – | – | 0.01% | 998 |
|
|
2023
Q1 | $225K | Sell |
9,377
-6,489
| -41% | -$156K | 0.01% | 1041 |
|
|
2022
Q4 | $269K | Hold |
15,866
| – | – | 0.01% | 959 |
|
|
2022
Q3 | $235K | Sell |
15,866
-4,480
| -22% | -$66.4K | 0.01% | 979 |
|
|
2022
Q2 | $320K | Hold |
20,346
| – | – | 0.01% | 830 |
|
|
2022
Q1 | $548K | Buy |
20,346
+2,655
| +15% | +$71.5K | 0.02% | 606 |
|
|
2021
Q4 | $654K | Sell |
17,691
-14,324
| -45% | -$530K | 0.03% | 405 |
|
|
2021
Q3 | $1.53M | Buy |
32,015
+106
| +0.3% | +$5.07K | 0.08% | 300 |
|
|
2021
Q2 | $1.08M | Sell |
31,909
-11,362
| -26% | -$384K | 0.05% | 355 |
|
|
2021
Q1 | $1.79M | Buy |
43,271
+13,328
| +45% | +$550K | 0.1% | 253 |
|
|
2020
Q4 | $1.3M | Buy |
29,943
+17,789
| +146% | +$772K | 0.09% | 267 |
|
|
2020
Q3 | $521K | Buy |
+12,154
| New | +$521K | 0.04% | 376 |
|